The majority of our patients had previously received anti-TNFα therapy (78% among the elderly and 91% among the younger group) and had undergone some IBD-related bowel surgery (60% of the elderly vs 63% of controls). The gene discussed is TNF; the disease is inflammatory bowel disease.